Frederick R. Appelbaum

powered by
COS Expertise®
Fred Hutchinson Cancer Research Center
Clinical Research
DirectorAppointed: 1993
Seattle Cancer Care Alliance
Executive DirectorAppointed: 1998
University of Washington
School of Medicine
Medicine
Head, Division of Medical OncologyAppointed: 1998
Fred Hutchinson Cancer Research Center
Clinical Research
MemberAppointed: 1988
University of Washington
School of Medicine
Medical Oncology
ProfessorAppointed: 1988
Professional Headshot of Frederick R. Appelbaum

Mailing Address

Fred Hutchinson Cancer Research Center
1100 Fairview Avenue North
P.O. Box 19024
D5-310
Seattle, Washington 98109-1024
United States

Contact Information

Phone: (206) 667-4412
Fax: (206) 667-6936
fappelba@fhcrc.org

Qualifications

M.D., Tufts University, 1972.
A.B. (cum laude), Dartmouth College, 1968.

Expertise and Research Interests

Our group is interested in developing an improved understanding of the biology of acute myeloid leukemia (AML) and using this knowledge to create novel therapeutic approaches. The following are several examples of such studies: (1) In one group of studies, we had previously shown that higher dose total body irradiation given in conjunction with hematopoietic cell transplantation was able to more reliably eradicate AML, but was associated with increased transplant-related toxicities. We have since shown the feasibility of targeting radiation therapy specifically to sites of normal and abnormal hematopoiesis using monoclonal antibodies against CD45 radiolabeled with 131I, and phase II trials incorporating this approach in transplant preparative regimens have yielded encouraging results. Current studies are aimed at further improving the specificity of targeting radiotherapy and defining the optimal way to apply this technique. (2) In a second group of experiments, we found that following exposure to cell-damaging agents, AML cells dramatically increase cellular cholesterol content and that blocking this response specifically sensitizes cells to chemotherapy. Subsequent clinical trials have demonstrated the feasibility of adding high dose pravastatin to leukemia induction therapy with encouraging clinical outcomes. We are currently attempting to conclusively define the role of cholesterol synthesis blockade in AML treatment. (3) In collaboration with the Southwest Oncology group, we have found that MDR1 mediated drug efflux in AML is increased in older patients and in patients with recurrent disease, and is tightly associated with drug resistance. We have completed studies showing an advantage of the use of MDR1 inhibition in patients with recurrent AML and are currently conducting clinical trials in the up-front treatment of older patients. In addition, we have identified novel compounds that inhibit not only drug efflux but the effects of BCL-2 overexpression and are attempting to define the optimal way in which to apply such therapy.


Banker, D.E., Mayer, S.J., Li, H.Y., Willman, C.L., Appelbaum, F.R., Zager, R.A. Cholesterol synthesis and import contribute to protective cholesterol increments in acute myeloid leukemia cells. Blood 104: 1816-1824, 2004.

Appelbaum,F.R., Gundacker,H., Head,D.R., Slovak,M.L., Willman,C.L., Godwin,J.E., Anderson,J.E., Petersdorf,S.H. Age and acute myeloid leukemia. Blood 107:3481-3485, 2006.

Larson,R.A., Sievers,E.L., Stadtmauer,E.A., Löwenberg,B., Estey,E.H., Dombret,H., Theobald,M., Voliotis,D., Bennett,J.M., Richie,M., Leopold,L.H., Berger,M.S., Sherman,M.L., Loken,M.R., van Dongen,J.J.M., Bernstein,I.D., Appelbaum,F.R. Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33-positive acute myeloid leukemia in first recurrence. Cancer 104: 1442-1452, 2005.

Pagel,J.M., Appelbaum,F.R., Eary,J.F., Rajendran,J., Fisher,D.R., Gooley,T., Ruffner,K., Nemecek,E., Sickle,E., Durack,L., Carreras,J., Horowitz,M.M., Press,O.W., Gopal,A.K., Martin,P.J., Bernstein,I.D., Matthews,D.C. 131I-anti-CD45 antibody plus busulfan and cyclophosphamide before allogeneic hematopoietic cell transplantation for treatment of acute myeloid leukemia in first remission. Blood 107: 2184-2191, 2006.

Walter,R.B., Pirga,J.L., Cronk,M.R., Mayer,S., Appelbaum,F.R., Banker,D.E. PK11195, a peripheral benzodiazepine receptor (pBR) ligand, broadly blocks drug efflux to chemosensitize leukemia and myeloma cells by a pBR-independent, direct transporter-modulating mechanism. Blood 106: 3584-3593, 2005.

Other Expertise

In addition to overseeing a laboratory focused on the biology of acute myeloid leukemia and chairing the Leukemia Committee of the Southwest Oncology Group, Dr. Appelbaum is the head of the Program in Clinical Transplant Research at the Fred Hutchinson Cancer Research Center. The overall goal of the Program in Clinical Transplant Research is to improve the therapy of cancer in children and adults through the conduct of clinical trials, many of which involve marrow and stem cell transplantation. Major topics of these trials include the eradication of malignancy, control of graft-vs-host disease, and prevention of transplant related complications.

Keywords

COS Keywords:

Cancer Biology, Leukemia, Oncology, Radiobiology, Tumors.

Additional Terms:

Cancer, Oncology, Tumor Biology.

Memberships

Alpha Omega Alpha
American Association for Cancer Research
American Society of Clinical Oncology
American Society of Hematology
International Society for Experimental Hematology

Publications

  • Hussein MA, Gundacker H, Head DR, Elias L, Foon KA, Boldt DH, Dobin SM, Dakhil SR, Budd GT, Appelbaum FR (Nov 2005) Cyclophosphamide followed by fludarabine for untreated chronic lymphocytic leukemia: a phase II SWOG TRIAL 9706., Leukemia : Official Journal of the Leukemia Society of America, Leukemia Research Fund, U.k., 19 (11), 1880-6 Abstract
  • Kerbauy DM, Chyou F, Gooley T, Sorror ML, Scott B, Pagel JM, Myerson D, Appelbaum FR, Storb R, Deeg HJ (Sep 2005) Allogeneic hematopoietic cell transplantation for chronic myelomonocytic leukemia., Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation., 11 (9), 713-20 Abstract
  • Nash RA, Johnston L, Parker P, McCune JS, Storer B, Slattery JT, Furlong T, Anasetti C, Appelbaum FR, Lloid ME, Deeg HJ, Kiem HP, Martin PJ, Schubert MM, Witherspoon RP, Forman SJ, Blume KG, Storb R (Jul 2005) A phase I/II study of mycophenolate mofetil in combination with cyclosporine for prophylaxis of acute graft-versus-host disease after myeloablative conditioning and allogeneic hematopoietic cell transplantation., Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation., 11 (7), 495-505 Abstract
  • Carpenter PA, Lowder J, Johnston L, Frangoul H, Khoury H, Parker P, Jerome KR, McCune JS, Storer B, Martin P, Appelbaum F, Abonour R, Westervelt P, Anasetti C (Jun 2005) A phase II multicenter study of visilizumab, humanized anti-CD3 antibody, to treat steroid-refractory acute graft-versus-host disease., Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation., 11 (6), 465-71 Abstract
  • Wallen H, Gooley TA, Deeg HJ, Pagel JM, Press OW, Appelbaum FR, Storb R, Gopal AK (May 2005) Ablative allogeneic hematopoietic cell transplantation in adults 60 years of age and older., Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology., 23 (15), 3439-46 Abstract
  • Sanders JE, Im HJ, Hoffmeister PA, Gooley TA, Woolfrey AE, Carpenter PA, Andrews RG, Bryant EM, Appelbaum FR (May 2005) Allogeneic hematopoietic cell transplantation for infants with acute lymphoblastic leukemia., Blood, 105 (9), 3749-56 Abstract
  • Appelbaum FR, Dose intensity and the toxicity and efficacy of allogeneic hematopoietic cell transplantation., Leukemia : Official Journal of the Leukemia Society of America, Leukemia Research Fund, U.k., 19(2), 171-5, Feb 2005 Abstract
  • Appelbaum FR (Feb 2005) Innovations in preparative regimens for autologous hematopoietic cell transplantation., Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation., 11 (2 Suppl 2), 40-2 Abstract
  • Flowers ME, Traina F, Storer B, Maris M, Bethge WA, Carpenter P, Appelbaum F, Storb R, Sandmaier BM, Martin PJ (Feb 2005) Serious graft-versus-host disease after hematopoietic cell transplantation following nonmyeloablative conditioning., Bone Marrow Transplantation, 35 (3), 277-82 Abstract
  • Sanders JE, Guthrie KA, Hoffmeister PA, Woolfrey AE, Carpenter PA, Appelbaum FR (Feb 2005) Final adult height of patients who received hematopoietic cell transplantation in childhood., Blood, 105 (3), 1348-54 Abstract
  • Oehler VG, Radich JP, Storer B, Blume KG, Chauncey T, Clift R, Snyder DS, Forman SJ, Flowers ME, Martin P, Guthrie KA, Negrin RS, Appelbaum FR, Bensinger W (Feb 2005) Randomized trial of allogeneic related bone marrow transplantation versus peripheral blood stem cell transplantation for chronic myeloid leukemia., Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation., 11 (2), 85-92 Abstract
  • Nemecek ER, Hamlin DK, Fisher DR, Krohn KA, Pagel JM, Appelbaum FR, Press OW, Matthews DC (Jan 2005) Biodistribution of yttrium-90-labeled anti-CD45 antibody in a nonhuman primate model., Clinical Cancer Research : an Official Journal of the American Association for Cancer Research., 11 (2 Pt 1), 787-94 Abstract
  • Scott BL, Storer B, Loken MR, Storb R, Appelbaum FR, Deeg HJ (Jan 2005) Pretransplantation induction chemotherapy and posttransplantation relapse in patients with advanced myelodysplastic syndrome., Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation., 11 (1), 65-73 Abstract
  • Byrd JC, Rai K, Peterson BL, Appelbaum FR, Morrison VA, Kolitz JE, Shepherd L, Hines JD, Schiffer CA, Larson RA (Jan 2005) Addition of rituximab to fludarabine may prolong progression-free survival and overall survival in patients with previously untreated chronic lymphocytic leukemia: an updated retrospective comparative analysis of CALGB 9712 and CALGB 901, Blood, 105 (1), 49-53 Abstract
  • Tse W, Joachim Deeg H, Stirewalt D, Appelbaum FR, Radich J, Gooley T (Jan 2005) Increased AF1q gene expression in high-risk myelodysplastic syndrome., British Journal of Haematology, 128 (2), 218-20 Abstract
  • Deeg HJ, Jiang PY, Holmberg LA, Scott B, Petersdorf EW, Appelbaum FR, Hematologic responses of patients with MDS to antithymocyte globulin plus etanercept correlate with improved flow scores of marrow cells, Leukemia Research, 28(11), 1177-80, Nov 2004 Abstract
  • Banker DE, Mayer SJ, Li HY, Willman CL, Appelbaum FR, Zager RA, Cholesterol synthesis and import contribute to protective cholesterol increments in acute myeloid leukemia cells, Blood, 104(6), 1816-24, Sep 2004 Abstract
  • Martin PJ, Pei J, Gooley T, Anasetti C, Appelbaum FR, Deeg J, Hansen JA, Nash RA, Petersdorf EW, Storb R, Ghetie V, Schindler J, Vitetta ES, Evaluation of a CD25-specific immunotoxin for prevention of graft-versus-host disease after unrelated marrow transplantation, Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation., 10(8), 552-60, Aug 2004 Abstract
  • Walter RB, Raden BW, Cronk MR, Bernstein ID, Appelbaum FR, Banker DE, The peripheral benzodiazepine receptor ligand PK11195 overcomes different resistance mechanisms to sensitize AML cells to gemtuzumab ozogamicin, Blood, 103(11), 4276-84, Jun 2004 Abstract
  • Martin PJ, McDonald GB, Sanders JE, Anasetti C, Appelbaum FR, Deeg HJ, Nash RA, Petersdorf EW, Hansen JA, Storb R, Increasingly frequent diagnosis of acute gastrointestinal graft-versus-host disease after allogeneic hematopoietic cell transplantation, Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation., 10(5), 320-7, May 2004 Abstract
  • Yusuf U, Frangoul HA, Gooley TA, Woolfrey AE, Carpenter PA, Andrews RG, Deeg HJ, Appelbaum FR, Anasetti C, Storb R, Sanders JE, Allogeneic bone marrow transplantation in children with myelodysplastic syndrome or juvenile myelomonocytic leukemia: the Seattle experience, Bone Marrow Transplantation, 33(8), 805-14, Apr 2004 Abstract
  • Appelbaum FR, Use of granulocyte colony-stimulating factor following hematopoietic cell transplantation: does haste make waste?, Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology., 22(3), 390-1, Feb 2004 Abstract
  • Appelbaum FR, Gundacker HM, Age and the nature of acute myeloid leukemia, Annals of Hematology, 83 Suppl 1, S106-7, 2004 Abstract
  • Randolph SS, Gooley TA, Warren EH, Appelbaum FR, Riddell SR, Female donors contribute to a selective graft-versus-leukemia effect in male recipients of HLA-matched, related hematopoietic stem cell transplants, Blood, 103(1), 347-52, Jan 2004 Abstract
  • Benesch M, McDonald GB, Schubert M, Appelbaum FR, Deeg HJ, Lack of cytoprotective effect of amifostine following HLA-identical sibling transplantation for advanced myelodysplastic syndrome (MDS): a pilot study, Bone Marrow Transplantation, 32(11), 1071-5, Dec 2003 Abstract
  • Deeg HJ, Gooley TA, Flowers ME, Sale GE, Slattery JT, Anasetti C, Chauncey TR, Doney K, Georges GE, Kiem HP, Martin PJ, Petersdorf EW, Radich J, Sanders JE, Sandmaier BM, Warren EH, Witherspoon RP, Storb R, Appelbaum FR, Allogeneic hematopoietic stem cell transplantation for myelofibrosis, Blood, 102(12), 3912-8, Dec 2003 Abstract
  • Maloney DG, Molina AJ, Sahebi F, Stockerl-Goldstein KE, Sandmaier BM, Bensinger W, Storer B, Hegenbart U, Somlo G, Chauncey T, Bruno B, Appelbaum FR, Blume KG, Forman SJ, McSweeney P, Storb R, Allografting with nonmyeloablative conditioning following cytoreductive autografts for the treatment of patients with multiple myeloma, Blood, 102(9), 3447-54, Nov 2003 Abstract
  • Gopal AK, Gooley TA, Maloney DG, Petersdorf SH, Eary JF, Rajendran JG, Bush SA, Durack LD, Golden J, Martin PJ, Matthews DC, Appelbaum FR, Bernstein ID, Press OW, High-dose radioimmunotherapy versus conventional high-dose therapy and autologous hematopoietic stem cell transplantation for relapsed follicular non-Hodgkin lymphoma: a multivariable coho, Blood, 102(7), 2351-7, Oct 2003 Abstract
  • Chen CS, Boeckh M, Seidel K, Clark JG, Kansu E, Madtes DK, Wagner JL, Witherspoon RP, Anasetti C, Appelbaum FR, Bensinger WI, Deeg HJ, Martin PJ, Sanders JE, Storb R, Storek J, Wade J, Siadak M, Flowers ME, Sullivan KM, Incidence, risk factors, and mortality from pneumonia developing late after hematopoietic stem cell transplantation, Bone Marrow Transplantation, 32(5), 515-22, Sep 2003 Abstract
  • Bornhauser M, Storer B, Slattery JT, Appelbaum FR, Deeg HJ, Hansen J, Martin PJ, McDonald GB, Nichols WG, Radich J, Woolfrey A, Jenke A, Schleyer E, Thiede C, Ehninger G, Anasetti C, Conditioning with fludarabine and targeted busulfan for transplantation of allogeneic hematopoietic stem cells, Blood, 102(3), 820-6, Aug 2003 Abstract
  • Doney K, Hagglund H, Leisenring W, Chauncey T, Appelbaum FR, Storb R, Predictive factors for outcome of allogeneic hematopoietic cell transplantation for adult acute lymphoblastic leukemia, Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation., 9(7), 472-81, Jul 2003 Abstract
  • Radich JP, Gooley T, Bensinger W, Chauncey T, Clift R, Flowers M, Martin P, Slattery J, Sultan D, Appelbaum FR, HLA-matched related hematopoietic cell transplantation for chronic-phase CML using a targeted busulfan and cyclophosphamide preparative regimen, Blood, 102(1), 31-5, Jul 2003 Abstract
  • Li HY, Appelbaum FR, Willman CL, Zager RA, Banker DE, Cholesterol-modulating agents kill acute myeloid leukemia cells and sensitize them to therapeutics by blocking adaptive cholesterol responses, Blood, 101(9), 3628-34, May 2003 Abstract
  • Gallagher RE, Yeap BY, Bi W, Livak KJ, Beaubier N, Rao S, Bloomfield CD, Appelbaum FR, Tallman MS, Slack JL, Willman CL, Quantitative real-time RT-PCR analysis of PML-RAR alpha mRNA in acute promyelocytic leukemia: assessment of prognostic significance in adult patients from intergroup protocol 0129, Blood, 101(7), 2521-8, Apr 2003 Abstract
  • Appelbaum FR, New targets for therapy in acute myeloid leukemia, Leukemia : Official Journal of the Leukemia Society of America, Leukemia Research Fund, U.k., 17(3), 492-5, Mar 2003 Abstract
  • Hsi ED, Kopecky KJ, Appelbaum FR, Boldt D, Frey T, Loftus M, Hussein MA, Prognostic significance of CD38 and CD20 expression as assessed by quantitative flow cytometry in chronic lymphocytic leukaemia, British Journal of Haematology, 120(6), 1017-25, Mar 2003 Abstract
  • Stirewalt DL, Appelbaum FR, Willman CL, Zager RA, Banker DE, Mevastatin can increase toxicity in primary AMLs exposed to standard therapeutic agents, but statin efficacy is not simply associated with ras hotspot mutations or overexpression, Leukemia Research, 27(2), 133-45, Feb 2003 Abstract
  • Appelbaum FR, The current status of hematopoietic cell transplantation, Annual Review of Medicine, 54, 491-512, 2003 Abstract
  • Feinstein LC, Sandmaier BM, Hegenbart U, McSweeney PA, Maloney DG, Gooley TA, Maris MB, Chauncey TR, Bruno B, Appelbaum FR, Niederwieser DW, Storb RF, Non-myeloablative allografting from human leucocyte antigen-identical sibling donors for treatment of acute myeloid leukaemia in first complete remission, British Journal of Haematology, 120(2), 281-8, Jan 2003 Abstract
  • Anderson JE, Kopecky KJ, Willman CL, Head D, O'Donnell MR, Luthardt FW, Norwood TH, Chen IM, Balcerzak SP, Johnson DB, Appelbaum FR, Outcome after induction chemotherapy for older patients with acute myeloid leukemia is not improved with mitoxantrone and etoposide compared to cytarabine and daunorubicin: a Southwest Onc, Blood, 100(12), 3869-76, Dec 2002 Abstract
  • Tallman MS, Andersen JW, Schiffer CA, Appelbaum FR, Feusner JH, Woods WG, Ogden A, Weinstein H, Shepherd L, Willman C, Bloomfield CD, Rowe JM, Wiernik PH, All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocol, Blood, 100(13), 4298-302, Dec 2002 Abstract
  • List AF, Kopecky KJ, Willman CL, Head DR, Slovak ML, Douer D, Dakhil SR, Appelbaum FR, Cyclosporine inhibition of P-glycoprotein in chronic myeloid leukemia blast phase, Blood, 100(5), 1910-2, Sep 2002 Abstract
  • Morrison VA, Rai KR, Peterson BL, Kolitz JE, Elias L, Appelbaum FR, Hines JD, Shepherd L, Larson RA, Schiffer CA, Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and l, Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology., 20(18), 3878-84, Sep 2002 Abstract
  • Larson RA, Boogaerts M, Estey E, Karanes C, Stadtmauer EA, Sievers EL, Mineur P, Bennett JM, Berger MS, Eten CB, Munteanu M, Loken MR, Van Dongen JJ, Bernstein ID, Appelbaum FR, Mylotarg Study Group, Antibody-targeted chemotherapy of older patients with acute myeloid leukemia in first relapse using Mylotarg (gemtuzumab ozogamicin), Leukemia : Official Journal of the Leukemia Society of America, Leukemia Research Fund, U.k., 16(9), 1627-36, Sep 2002 Abstract
  • McCune JS, Gooley T, Gibbs JP, Sanders JE, Petersdorf EW, Appelbaum FR, Anasetti C, Risler L, Sultan D, Slattery JT, Busulfan concentration and graft rejection in pediatric patients undergoing hematopoietic stem cell transplantation, Bone Marrow Transplantation, 30(3), 167-73, Aug 2002 Abstract
  • Deeg HJ, Storer B, Slattery JT, Anasetti C, Doney KC, Hansen JA, Kiem HP, Martin PJ, Petersdorf E, Radich JP, Sanders JE, Shulman HM, Warren EH, Witherspoon RP, Bryant EM, Chauncey TR, Getzendaner L, Storb R, Appelbaum FR, Conditioning with targeted busulfan and cyclophosphamide for hemopoietic stem cell transplantation from related and unrelated donors in patients with myelodysplastic syndrome, Blood, 100(4), 1201-7, Aug 2002 Abstract
  • Wolman SR, Gundacker H, Appelbaum FR, Slovak ML, Southwest Oncology Group, Impact of trisomy 8 (+8) on clinical presentation, treatment response, and survival in acute myeloid leukemia: a Southwest Oncology Group study, Blood, 100(1), 29-35, Jul 2002 Abstract
  • Flowers ME, Parker PM, Johnston LJ, Matos AV, Storer B, Bensinger WI, Storb R, Appelbaum FR, Forman SJ, Blume KG, Martin PJ, Comparison of chronic graft-versus-host disease after transplantation of peripheral blood stem cells versus bone marrow in allogeneic recipients: long-term follow-up of a randomized trial, Blood, 100(2), 415-9, Jul 2002 Abstract
  • Koc S, Leisenring W, Flowers ME, Anasetti C, Deeg HJ, Nash RA, Sanders JE, Witherspoon RP, Storb R, Appelbaum FR, Martin PJ, Therapy for chronic graft-versus-host disease: a randomized trial comparing cyclosporine plus prednisone versus prednisone alone, Blood, 100(1), 48-51, Jul 2002 Abstract
  • Platzbecker U, Gooley T, Anasetti C, Appelbaum FR, Clurman B, Doney K, Chauncey T, Flowers ME, Myerson D, Radich JP, Storb R, Witherspoon RP, Deeg HJ, Curative therapy of advanced essential thrombocythemia or polycythemia vera by hemopoietic stem cell transplantation, Leukemia & Lymphoma, 43(7), 1409-14, Jul 2002 Abstract
  • Doney KC, Chauncey T, Appelbaum FR, Seattle Bone Marrow Transplant Team, Allogeneic related donor hematopoietic stem cell transplantation for treatment of chronic lymphocytic leukemia, Bone Marrow Transplantation, 29(10), 817-23, May 2002 Abstract
  • Pagel JM, Matthews DC, Appelbaum FR, Bernstein ID, Press OW, The use of radioimmunoconjugates in stem cell transplantation, Bone Marrow Transplantation, 29(10), 807-16, May 2002 Abstract
  • Gopal AK, Rajendran JG, Petersdorf SH, Maloney DG, Eary JF, Wood BL, Gooley TA, Bush SA, Durack LD, Martin PJ, Matthews DC, Appelbaum FR, Bernstein ID, Press OW, High-dose chemo-radioimmunotherapy with autologous stem cell support for relapsed mantle cell lymphoma, Blood, 99(9), 3158-62, May 2002 Abstract
  • Appelbaum FR, Hematopoietic cell transplantation as a form of immunotherapy, International Journal of Hematology, 75(3), 222-7, Apr 2002 Abstract
  • Appelbaum FR, Sandmaier B, Sensitivity of renal cell cancer to nonmyeloablative allogeneic hematopoietic cell transplantations: unusual or unusually important?, Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology., 20(8), 1965-7, Apr 2002 Abstract
  • Carpenter PA, Appelbaum FR, Corey L, Deeg HJ, Doney K, Gooley T, Krueger J, Martin P, Pavlovic S, Sanders J, Slattery J, Levitt D, Storb R, Woolfrey A, Anasetti C, A humanized non-FcR-binding anti-CD3 antibody, visilizumab, for treatment of steroid-refractory acute graft-versus-host disease, Blood, 99(8), 2712-9, Apr 2002 Abstract
  • Woolfrey AE, Anasetti C, Storer B, Doney K, Milner LA, Sievers EL, Carpenter P, Martin P, Petersdorf E, Appelbaum FR, Hansen JA, Sanders JE, Factors associated with outcome after unrelated marrow transplantation for treatment of acute lymphoblastic leukemia in children, Blood, 99(6), 2002-8, Mar 2002 Abstract
  • Appelbaum FR, Hematopoietic cell transplantation beyond first remission, Leukemia : Official Journal of the Leukemia Society of America, Leukemia Research Fund, U.k., 16(2), 157-9, Feb 2002 Abstract
  • Banker DE, Cooper JJ, Fennell DA, Willman CL, Appelbaum FR, Cotter FE, PK11195, a peripheral benzodiazepine receptor ligand, chemosensitizes acute myeloid leukemia cells to relevant therapeutic agents by more than one mechanism, Leukemia Research, 26(1), 91-106, Jan 2002 Abstract
  • Hoelzer D, Gokbuget N, Ottmann O, Pui CH, Relling MV, Appelbaum FR, van Dongen JJ, Szczepanski T, Acute lymphoblastic leukemia, Hematology / the Education Program of the American Society of Hematology American Society of Hematology. Education Program., 162-92, 2002 Abstract
  • Furlong T, Leisenring W, Storb R, Anasetti C, Appelbaum FR, Carpenter PA, Deeg HJ, Doney K, Kiem HP, Nash RA, Sanders JE, Witherspoon R, Thompson D, Martin PJ, Psoralen and ultraviolet A irradiation (PUVA) as therapy for steroid-resistant cutaneous acute graft-versus-host disease, Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation., 8(4), 206-12, 2002 Abstract
  • Kansu E, Gooley T, Flowers ME, Anasetti C, Deeg HJ, Nash RA, Sanders JE, Witherspoon RP, Appelbaum FR, Storb R, Martin PJ, Administration of cyclosporine for 24 months compared with 6 months for prevention of chronic graft-versus-host disease: a prospective randomized clinical trial, Blood, 98(13), 3868-70, Dec 2001 Abstract
  • Benito AI, Furlong T, Martin PJ, Anasetti C, Appelbaum FR, Doney K, Nash RA, Papayannopoulou T, Storb R, Sullivan KM, Witherspoon R, Deeg HJ, Sirolimus (rapamycin) for the treatment of steroid-refractory acute graft-versus-host disease, Transplantation, 72(12), 1924-9, Dec 2001 Abstract
  • List AF, Kopecky KJ, Willman CL, Head DR, Persons DL, Slovak ML, Dorr R, Karanes C, Hynes HE, Doroshow JH, Shurafa M, Appelbaum FR, Benefit of cyclosporine modulation of drug resistance in patients with poor-risk acute myeloid leukemia: a Southwest Oncology Group study, Blood, 98(12), 3212-20, Dec 2001 Abstract
  • Storek J, Joseph A, Espino G, Dawson MA, Douek DC, Sullivan KM, Flowers ME, Martin P, Mathioudakis G, Nash RA, Storb R, Appelbaum FR, Maloney DG, Immunity of patients surviving 20 to 30 years after allogeneic or syngeneic bone marrow transplantation, Blood, 98(13), 3505-12, Dec 2001 Abstract
  • Gutierrez-Delgado F, Maloney DG, Press OW, Golden J, Holmberg LA, Maziarz RT, Hooper H, Buckner CD, Appelbaum FR, Bensinger WI, Autologous stem cell transplantation for non-Hodgkin's lymphoma: comparison of radiation-based and chemotherapy-only preparative regimens, Bone Marrow Transplantation, 28(5), 455-61, Sep 2001 Abstract
  • Radich JP, Gooley T, Bryant E, Chauncey T, Clift R, Beppu L, Edmands S, Flowers ME, Kerkof K, Nelson R, Appelbaum FR, The significance of bcr-abl molecular detection in chronic myeloid leukemia patients "late," 18 months or more after transplantation, Blood, 98(6), 1701-7, Sep 2001 Abstract
  • Linenberger ML, Hong T, Flowers D, Sievers EL, Gooley TA, Bennett JM, Berger MS, Leopold LH, Appelbaum FR, Bernstein ID, Multidrug-resistance phenotype and clinical responses to gemtuzumab ozogamicin, Blood, 98(4), 988-94, Aug 2001 Abstract
  • Morrison VA, Rai KR, Peterson BL, Kolitz JE, Elias L, Appelbaum FR, Hines JD, Shepherd L, Martell RE, Larson RA, Schiffer CA, Impact of therapy With chlorambucil, fludarabine, or fludarabine plus chlorambucil on infections in patients with chronic lymphocytic leukemia: Intergroup Study Cancer and Leukemia Group B, Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology., 19(16), 3611-21, Aug 2001 Abstract
  • Anderson JE, Tefferi A, Craig F, Holmberg L, Chauncey T, Appelbaum FR, Guardiola P, Callander N, Freytes C, Gazitt Y, Razvillas B, Deeg HJ, Myeloablation and autologous peripheral blood stem cell rescue results in hematologic and clinical responses in patients with myeloid metaplasia with myelofibrosis, Blood, 98(3), 586-93, Aug 2001 Abstract
  • Appelbaum FR, Perspectives on the future of chronic myeloid leukemia treatment, Seminars in Hematology, 38(3 Suppl 8), 35-42, Jul 2001 Abstract
  • Sievers EL, Larson RA, Stadtmauer EA, Estey E, Lowenberg B, Dombret H, Karanes C, Theobald M, Bennett JM, Sherman ML, Berger MS, Eten CB, Loken MR, van Dongen JJ, Bernstein ID, Appelbaum FR, Mylotarg Study Group, Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse, Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology., 19(13), 3244-54, Jul 2001 Abstract
  • Stirewalt DL, Kopecky KJ, Meshinchi S, Appelbaum FR, Slovak ML, Willman CL, Radich JP, FLT3, RAS, and TP53 mutations in elderly patients with acute myeloid leukemia, Blood, 97(11), 3589-95, Jun 2001 Abstract
  • Storek J, Dawson MA, Storer B, Stevens-Ayers T, Maloney DG, Marr KA, Witherspoon RP, Bensinger W, Flowers ME, Martin P, Storb R, Appelbaum FR, Boeckh M, Immune reconstitution after allogeneic marrow transplantation compared with blood stem cell transplantation, Blood, 97(11), 3380-9, Jun 2001 Abstract
  • McSweeney PA, Niederwieser D, Shizuru JA, Sandmaier BM, Molina AJ, Maloney DG, Chauncey TR, Gooley TA, Hegenbart U, Nash RA, Radich J, Wagner JL, Minor S, Appelbaum FR, Bensinger WI, Bryant E, Flowers ME, Georges GE, Grumet FC, Kiem HP, Torok-Storb B, Yu, Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects, Blood, 97(11), 3390-400, Jun 2001 Abstract
  • Appelbaum FR, Haematopoietic cell transplantation as immunotherapy, Nature, 411(6835), 385-9, May 2001 Abstract
  • Rowley SD, Donaldson G, Lilleby K, Bensinger WI, Appelbaum FR, Experiences of donors enrolled in a randomized study of allogeneic bone marrow or peripheral blood stem cell transplantation, Blood, 97(9), 2541-8, May 2001 Abstract
  • Al-Ghamdi H, Leisenring W, Bensinger WI, Nash RA, Storb R, Appelbaum FR, Martin PJ, A proposed objective way to assess results of randomized prospective clinical trials with acute graft-versus-host disease as an outcome of interest, British Journal of Haematology, 113(2), 461-9, May 2001 Abstract
  • Appelbaum FR, Who should be transplanted for AML?, Leukemia : Official Journal of the Leukemia Society of America, Leukemia Research Fund, U.k., 15(4), 680-2, Apr 2001 Abstract
  • Garrido SM, Appelbaum FR, Willman CL, Banker DE, Acute myeloid leukemia cells are protected from spontaneous and drug-induced apoptosis by direct contact with a human bone marrow stromal cell line (HS-5), Experimental Hematology, 29(4), 448-57, Apr 2001 Abstract
  • Witherspoon RP, Deeg HJ, Storer B, Anasetti C, Storb R, Appelbaum FR, Hematopoietic stem-cell transplantation for treatment-related leukemia or myelodysplasia, Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology., 19(8), 2134-41, Apr 2001 Abstract
  • Deeg HJ, Appelbaum FR, Stem-cell transplantation for myelofibrosis, The New England Journal of Medicine, 344(10), 775-6, Mar 2001 Abstract
  • Gopal AK, Gooley TA, Golden JB, Maloney DG, Bensinger WI, Petersdorf SH, Appelbaum FR, Press OW, Efficacy of high-dose therapy and autologous hematopoietic stem cell transplantation for non-Hodgkin's lymphoma in adults 60 years of age and older, Bone Marrow Transplantation, 27(6), 593-9, Mar 2001 Abstract
  • Petersdorf SH, Kopecky KJ, Head DR, Boldt DH, Balcerzak SP, Wun T, Roy V, Veith RW, Appelbaum FR, Comparison of the L10M consolidation regimen to an alternative regimen including escalating methotrexate/L-asparaginase for adult acute lymphoblastic leukemia: a Southwest Oncology Group , Leukemia : Official Journal of the Leukemia Society of America, Leukemia Research Fund, U.k., 15(2), 208-16, Feb 2001 Abstract
  • Appelbaum FR, Rowe JM, Radich J, Dick JE, Acute myeloid leukemia, Hematology / the Education Program of the American Society of Hematology American Society of Hematology. Education Program., 62-86, 2001 Abstract
  • Garrido SM, Cooper JJ, Appelbaum FR, Willman CL, Kopecky K, Banker DE, Blasts from elderly acute myeloid leukemia patients are characterized by low levels of culture- and drug-induced apoptosis, Leukemia Research, 25(1), 23-32, Jan 2001 Abstract
  • Bennett CL, Hynes D, Godwin J, Stinson TJ, Golub RM, Appelbaum FR, Southwest Oncology Group, Economic analysis of granulocyte colony stimulating factor as adjunct therapy for older patients with acute myelogenous leukemia (AML): estimates from a Southwest Oncology Group clinical , Cancer Investigation, 19(6), 603-10, 2001 Abstract
  • Anderson JE, Appelbaum FR, Schoch G, Barnett T, Chauncey TR, Flowers ME, Storb R, Relapse after allogeneic bone marrow transplantation for refractory anemia is increased by shielding lungs and liver during total body irradiation, Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation., 7(3), 163-70, 2001 Abstract
  • Bensinger WI, Martin PJ, Storer B, Clift R, Forman SJ, Negrin R, Kashyap A, Flowers ME, Lilleby K, Chauncey TR, Storb R, Appelbaum FR, Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers, The New England Journal of Medicine, 344(3), 175-81, Jan 2001 Abstract
  • Storb R, Blume KG, O'Donnell MR, Chauncey T, Forman SJ, Deeg HJ, Hu WW, Appelbaum FR, Doney K, Flowers ME, Sanders J, Leisenring W, Cyclophosphamide and antithymocyte globulin to condition patients with aplastic anemia for allogeneic marrow transplantations: the experience in four centers, Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation., 7(1), 39-44, 2001 Abstract
  • Rai KR, Peterson BL, Appelbaum FR, Kolitz J, Elias L, Shepherd L, Hines J, Threatte GA, Larson RA, Cheson BD, Schiffer CA, Fludarabine compared with chlorambucil as primary therapy for chronic lymphocytic leukemia, The New England Journal of Medicine, 343(24), 1750-7, Dec 2000 Abstract
  • Koc S, Leisenring W, Flowers ME, Anasetti C, Deeg HJ, Nash RA, Sanders JE, Witherspoon RP, Appelbaum FR, Storb R, Martin PJ, Thalidomide for treatment of patients with chronic graft-versus-host disease, Blood, 96(12), 3995-6, Dec 2000 Abstract
  • Slovak ML, Kopecky KJ, Cassileth PA, Harrington DH, Theil KS, Mohamed A, Paietta E, Willman CL, Head DR, Rowe JM, Forman SJ, Appelbaum FR, Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study, Blood, 96(13), 4075-83, Dec 2000 Abstract
  • Furlong T, Storb R, Anasetti C, Appelbaum FR, Deeg HJ, Doney K, Martin P, Sullivan K, Witherspoon R, Nash RA, Clinical outcome after conversion to FK 506 (tacrolimus) therapy for acute graft-versus-host disease resistant to cyclosporine or for cyclosporine-associated toxicities, Bone Marrow Transplantation, 26(9), 985-91, Nov 2000 Abstract
  • Appelbaum FR, Baer MR, Carabasi MH, Coutre SE, Erba HP, Estey E, Glenn MJ, Kraut EH, Maslak P, Millenson M, Miller CB, Saba HI, Stone R, Tallman MS, National Comprehensive Cancer Network, NCCN Practice Guidelines for Acute Myelogenous Leukemia, Oncology (williston Park, N.y.), 14(11A), 53-61, Nov 2000 Abstract
  • Press OW, Eary JF, Gooley T, Gopal AK, Liu S, Rajendran JG, Maloney DG, Petersdorf S, Bush SA, Durack LD, Martin PJ, Fisher DR, Wood B, Borrow JW, Porter B, Smith JP, Matthews DC, Appelbaum FR, Bernstein ID, A phase I/II trial of iodine-131-tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomas, Blood, 96(9), 2934-42, Nov 2000 Abstract
  • Koc S, Hagglund H, Ireton RC, Perez-Simon JA, Collins SJ, Appelbaum FR, Successful treatment of severe hemorrhagic cystitis with cystectomy following matched donor allogeneic hematopoietic cell transplantation, Bone Marrow Transplantation, 26(8), 899-901, Oct 2000 Abstract
  • Deeg HJ, Appelbaum FR, Hematopoietic stem cell transplantation in patients with myelodysplastic syndrome, Leukemia Research, 24(8), 653-63, Aug 2000 Abstract
  • Deeg HJ, Flowers ME, Leisenring W, Appelbaum FR, Martin PJ, Storb RF, Cyclosporine (CSP)or CSP plus methylprednisolone for graft-versus-host disease prophylaxis in patients with high-risk lymphohemopoietic malignancies: long-term follow-up of a randomized tr, Blood, 96(3), 1194-5, Aug 2000 Abstract
  • Sierra J, Storer B, Hansen JA, Martin PJ, Petersdorf EW, Woolfrey A, Matthews D, Sanders JE, Storb R, Appelbaum FR, Anasetti C, Unrelated donor marrow transplantation for acute myeloid leukemia: an update of the Seattle experience, Bone Marrow Transplantation, 26(4), 397-404, Aug 2000 Abstract
  • Zhang FF, Murata-Collins JL, Gaytan P, Forman SJ, Kopecky KJ, Willman CL, Appelbaum FR, Slovak ML, Twenty-four-color spectral karyotyping reveals chromosome aberrations in cytogenetically normal acute myeloid leukemia, Genes, Chromosomes & Cancer, 28(3), 318-28, Jul 2000 Abstract
  • Gutierrez-Delgado F, Holmberg LA, Hooper H, Appelbaum FR, Livingston RB, Maziarz RT, Weiden P, Rivkin S, Montgomery P, Kawahara K, Bensinger W, High-dose busulfan, melphalan and thiotepa as consolidation for non-inflammatory high-risk breast cancer, Bone Marrow Transplantation, 26(1), 51-9, Jul 2000 Abstract
  • Chauncey TR, Rankin C, Anderson JE, Chen I, Kopecky KJ, Godwin JE, Kalaycio ME, Moore DF, Shurafa MS, Petersdorf SH, Kraut EH, Leith CP, Head DR, Luthardt FW, Willman CL, Appelbaum FR, A phase I study of induction chemotherapy for older patients with newly diagnosed acute myeloid leukemia (AML) using mitoxantrone, etoposide, and the MDR modulator PSC 833: a southwest onc, Leukemia Research, 24(7), 567-74, Jul 2000 Abstract
  • Garrido SM, Bryant E, Appelbaum FR, Allogeneic stem cell transplantation for relapsed and refractory acute myeloid leukemia patients with 11q23 abnormalities, Leukemia Research, 24(6), 481-6, Jun 2000 Abstract
  • Crump C, Chen C, Appelbaum FR, Kopecky KJ, Schwartz SM, Willman CL, Slovak ML, Weiss NS, Glutathione S-transferase theta 1 gene deletion and risk of acute myeloid leukemia, Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology., 9(5), 457-60, May 2000 Abstract
  • Garrido SM, Willman C, Appelbaum FR, Banker DE, Three-color versus four-color multiparameter cell cycle analyses of primary acute myeloid leukemia samples, Cytometry : the Journal of the Society for Analytical Cytology, 42(2), 83-94, Apr 2000 Abstract
  • Appelbaum FR, Is there a best transplant conditioning regimen for acute myeloid leukemia?, Leukemia : Official Journal of the Leukemia Society of America, Leukemia Research Fund, U.k., 14(3), 497-501, Mar 2000 Abstract
  • Deeg HJ, Appelbaum FR, Hemopoietic stem cell transplantation for myelodysplastic syndrome, Current Opinion in Oncology, 12(2), 116-20, Mar 2000 Abstract
  • Rosen PJ, Rankin C, Head DR, Boldt DH, Luthardt FW, Norwood T, Pugh RP, Karanes C, Appelbaum FR, A phase II study of high dose ARA-C and mitoxantrone for treatment of relapsed or refractory adult acute lymphoblastic leukemia, Leukemia Research, 24(3), 183-7, Mar 2000 Abstract
  • Deeg HJ, Shulman HM, Anderson JE, Bryant EM, Gooley TA, Slattery JT, Anasetti C, Fefer A, Storb R, Appelbaum FR, Allogeneic and syngeneic marrow transplantation for myelodysplastic syndrome in patients 55 to 66 years of age, Blood, 95(4), 1188-94, Feb 2000 Abstract
  • Tallman MS, Andersen JW, Schiffer CA, Appelbaum FR, Feusner JH, Ogden A, Shepherd L, Rowe JM, Francois C, Larson RS, Wiernik PH, Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome., Blood, 95(1), 90-5, 1 2000 Abstract
  • Radich JP, Gooley T, Sanders JE, Anasetti C, Chauncey T, Appelbaum FR, Second allogeneic transplantation after failure of first autologous transplantation, Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation., 6(3), 272-9, 2000 Abstract
  • Cavallaro AM, Lilleby K, Majolino I, Storb R, Appelbaum FR, Rowley SD, Bensinger WI, Three to six year follow-up of normal donors who received recombinant human granulocyte colony-stimulating factor, Bone Marrow Transplantation, 25(1), 85-9, Jan 2000 Abstract
  • Nash RA, Kurzrock R, DiPersio J, Vose J, Linker C, Maharaj D, Nademanee AP, Negrin R, Nimer S, Shulman H, Ashby M, Jones D, Appelbaum FR, Champlin R, A phase I trial of recombinant human thrombopoietin in patients with delayed platelet recovery after hematopoietic stem cell transplantation, Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation., 6(1), 25-34, 2000 Abstract
  • Flowers ME, Leisenring W, Beach K, Riddell S, Radich JP, Higano CS, Rowley SD, Chauncey TR, Sanders JE, Anasetti C, Storb R, Wade J, Appelbaum FR, Martin P, Granulocyte colony-stimulating factor given to donors before apheresis does not prevent aplasia in patients treated with donor leukocyte infusion for recurrent chronic myeloid leukemia aft, Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation., 6(3A), 321-6, 2000 Abstract
  • Holmberg LA, Boeckh M, Hooper H, Leisenring W, Rowley S, Heimfeld S, Press O, Maloney DG, McSweeney P, Corey L, Maziarz RT, Appelbaum FR, Bensinger W, Increased incidence of cytomegalovirus disease after autologous CD34-selected peripheral blood stem cell transplantation., Blood, 94(12), 4029-35, 15 Dec 1999 Abstract
  • Clift RA, Radich J, Appelbaum FR, Martin P, Flowers ME, Deeg HJ, Storb R, Thomas ED, Long-term follow-up of a randomized study comparing cyclophosphamide and total body irradiation with busulfan and cyclophosphamide for patients receiving allogenic marrow transplants durin, Blood, 94(11), 3960-2, Dec 1999 Abstract
  • Appelbaum FR, Antibody-targeted therapy for myeloid leukemia, Seminars in Hematology, 36(4 Suppl 6), 2-8, October 1999 Abstract
  • Appelbaum FR, Molecular diagnosis and clinical decisions in adult acute leukemia, Seminars in Hematology, 36(4), 401-10, Oct 1999 Abstract
  • Martin PJ, Rowley SD, Anasetti C, Chauncey TR, Gooley T, Petersdorf EW, van Burik JA, Flowers ME, Storb R, Appelbaum FR, Hansen JA, A phase I-II clinical trial to evaluate removal of CD4 cells and partial depletion of CD8 cells from donor marrow for HLA-mismatched unrelated recipients, Blood, 94(7), 2192-9, Oct 1999 Abstract
  • Karanes C, Kopecky KJ, Head DR, Grever MR, Hynes HE, Kraut EH, Vial RH, Lichtin A, Nand S, Samlowski WE, Appelbaum FR, A phase III comparison of high dose ARA-C \(HIDAC\) versus HIDAC plus mitoxantrone in the treatment of first relapsed or refractory acute myeloid leukemia Southwest Oncology Group Study., Leukemia Research, 23(9), 787-94, September 1999 Abstract
  • Silver RT, Woolf SH, Hehlmann R, Appelbaum FR, Anderson J, Bennett C, Goldman JM, Guilhot F, Kantarjian HM, Lichtin AE, Talpaz M, Tura S, An evidence-based analysis of the effect of busulfan, hydroxyurea, interferon, and allogeneic bone marrow transplantation in treating the chronic phase of chronic myeloid leukemia: develop, Blood, 94(5), 1517-36, Sep 1999 Abstract
  • Matthews DC, Appelbaum FR, Eary JF, Fisher DR, Durack LD, Hui TE, Martin PJ, Mitchell D, Press OW, Storb R, Bernstein ID, Phase I study of \(131\)I-anti-CD45 antibody plus cyclophosphamide and total body irradiation for advanced acute leukemia and myelodysplastic syndrome., Blood, 94(4), 1237-47, 15 Aug 1999 Abstract
  • Leith CP, Kopecky KJ, Chen IM, Eijdems L, Slovak ML, McConnell TS, Head DR, Weick J, Grever MR, Appelbaum FR, Willman CL, Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia: a Southwest Oncology Group Study., Blood, 94(3), 1086-99, 1 Aug 1999 Abstract
  • Stirewalt DL, Clurman B, Appelbaum FR, Willman CL, Radich JP, p73 mutations and expression in adult de novo acute myelogenous leukemia., Leukemia, 13(7), 985-90, July 1999 Abstract
  • Appelbaum FR, Choosing the source of stem cells for allogeneic transplantation: no longer a peripheral issue, Blood, 94(2), 381-3, July 1999 Abstract
  • Gibbs JP, Gooley T, Corneau B, Murray G, Stewart P, Appelbaum FR, Slattery JT, The impact of obesity and disease on busulfan oral clearance in adults., Blood, 93(12), 4436-40, 15 Jun 1999 Abstract
  • Sievers EL, Appelbaum FR, Spielberger RT, Forman SJ, Flowers D, Smith FO, Shannon-Dorcy K, Berger MS, Bernstein ID, Selective ablation of acute myeloid leukemia using antibody-targeted chemotherapy: a phase I study of an anti-CD33 calicheamicin immunoconjugate., Blood, 93(11), 3678-84, 1 Jun 1999 Abstract
  • Li Q, Kopecky KJ, Mohan A, Willman CL, Appelbaum FR, Weick JK, Issa JP, Estrogen receptor methylation is associated with improved survival in adult acute myeloid leukemia, Clinical Cancer Research : an Official Journal of the American Association for Cancer Research., 5(5), 1077-84, May 1999 Abstract
  • Matthews DC, Martin PJ, Nourigat C, Appelbaum FR, Fisher DR, Bernstein ID, Marrow ablative and immunosuppressive effects of 131I-anti-CD45 antibody in congenic and H2-mismatched murine transplant models., Blood, 93(2), 737-45, 15 Jan 1999 Abstract
  • Storb R, Raff RF, Graham T, Appelbaum FR, Deeg HJ, Schuening FG, Sale G, Seidel K, Dose rate-dependent marrow toxicity of TBI in dogs and marrow sparing effect at high dose rate by dose fractionation., Biology of Blood and Marrow Transplantation, 5(3), 155-61, 1999 Abstract
  • D.R, Weick, J, Grever, M.R, Appelbaum, F.R, and Willman, C.L. Leith, C.P, Kopecky, K.J, Chen, I-M, Eijdems, L, Slovak, M.L, McConnell, T.S., Head, Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia patients less than 70 years old. A Sout, Blood, 94, 1086-1099, 1999
  • Banker DE, Radich J, Becker A, Kerkof K, Norwood T, Willman C, Appelbaum FR, The t(8;21) translocation is not consistently associated with high Bcl-2 expression in de novo acute myeloid leukemias of adults, Clinical Cancer Research : an Official Journal of the American Association for Cancer Research., 4(12), 3051-62, Dec 1998 Abstract
  • Cassileth PA, Harrington DP, Appelbaum FR, Lazarus HM, Rowe JM, Paietta E, Willman C, Hurd DD, Bennett JM, Blume KG, Head DR, Wiernik PH, Chemotherapy compared with autologous or allogeneic bone marrow transplantation in the management of acute myeloid leukemia in first remission, The New England Journal of Medicine, 339(23), 1649-56, Dec 1998 Abstract
  • Woolfrey AE, Gooley TA, Sievers EL, Milner LA, Andrews RG, Walters M, Hoffmeister P, Hansen JA, Anasetti C, Bryant E, Appelbaum FR, Sanders JE, Bone marrow transplantation for children less than 2 years of age with acute myelogenous leukemia or myelodysplastic syndrome, Blood, 92(10), 3546-56, Nov 1998 Abstract
  • Holmberg LA, Demirer T, Rowley S, Buckner CD, Goodman G, Maziarz R, Klarnet J, Zuckerman N, Harrer G, McCloskey R, Gersh R, Goldberg R, Nichols W, Jacobs A, Weiden P, Montgomery P, Rivkin S, Appelbaum FR, Bensinger WI, High-dose busulfan, melphalan and thiotepa followed by autologous peripheral blood stem cell \(PBSC\) rescue in patients with advanced stage III/IV ovarian cancer., Bone Marrow Transplantation, 22(7), 651-9, October 1998 Abstract
  • Liu SY, Eary JF, Petersdorf SH, Martin PJ, Maloney DG, Appelbaum FR, Matthews DC, Bush SA, Durack LD, Fisher DR, Gooley TA, Bernstein ID, Press OW, Follow-up of relapsed B-cell lymphoma patients treated with iodine-131-labeled anti-CD20 antibody and autologous stem-cell rescue, Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology., 16(10), 3270-8, Oct 1998 Abstract
  • Ren S, Kalhorn T F, McDonald G B, Anasetti C, Appelbaum F R, Slattery J T, Pharmacokinetics of cyclophosphamide and its metabolites in bone marrow transplantation patients., Clinical Pharmacology and Therapeutics, 64(3), 289-301, September 1998 Abstract
  • Appelbaum FR, Anderson J, Allogeneic bone marrow transplantation for myelodysplastic syndrome: outcomes analysis according to IPSS score, Leukemia : Official Journal of the Leukemia Society of America, Leukemia Research Fund, U.k., 12 Suppl 1, S25-9, Sep 1998 Abstract
  • Clift R A, Buckner C D, Appelbaum F R, Sullivan K M, Storb R, Thomas E D, Long-term follow-Up of a randomized trial of two irradiation regimens for patients receiving allogeneic marrow transplants during first remission of acute myeloid leukemia [letter], Blood, 92(4), 1455-6, 15 Aug 1998 Abstract
  • Morton A J, Gooley T, Hansen J A, Appelbaum F R, Bruemmer B, Bjerke J W, Clift R, Martin P J, Petersdorf E W, Sanders J E, Storb R, Sullivan K M, Woolfrey A, Anasetti C, Association between pretransplant interferon-alpha and outcome after unrelated donor marrow transplantation for chronic myelogenous leukemia in chronic phase., Blood, 92(2), 394-401, 15 Jul 1998 Abstract
  • Sullivan K M, Anasetti C, Horowitz M, Rowlings P A, Petersdorf E W, Martin P J, Clift R A, Walters M C, Gooley T, Sierra J, Anderson J E, Bjerke J, Siadak M, Flowers M E, Nash R A, Sanders J E, Appelbaum F R, Storb R, Hansen J A, Unrelated and HLA-nonidentical related donor marrow transplantation for thalassemia and leukemia. A combined report from the Seattle Marrow Transplant Team and the International Bone Marrow Transplant, Annals of The New York Academy of Sciences, 850, 312-24, 30 Jun 1998 Abstract
  • Godwin J E, Kopecky K J, Head D R, Willman C L, Leith C P, Hynes H E, Balcerzak S P, Appelbaum F R, A double-blind placebo-controlled trial of granulocyte colony-stimulating factor in elderly patients with previously untreated acute myeloid leukemia: a Southwest oncology group study (9031)., Blood, 91(10), 3607-15, 15 May 1998 Abstract
  • Appelbaum F R, Anderson J, Bone marrow transplantation for myelodysplasia in adults and children: when and who?, Leukemia Research, 22 Suppl 1, S35-9, May 1998 Abstract
  • Sandmaier B M, Storb R, Bennett K L, Appelbaum F R, Santos E B, Epitope specificity of CD44 for monoclonal antibody-dependent facilitation of marrow engraftment in a canine model., Blood, 91(9), 3494-502, 1 May 1998 Abstract
  • Storb R, Raff R, Deeg H J, Graham T, Appelbaum F R, Schuening F G, Shulman H, Seidel K, Leisenring W, Dose rate-dependent sparing of the gastrointestinal tract by fractionated total body irradiation in dogs given marrow autografts., International Journal of Radiation Oncology, Biology, Physics, 40(4), 961-6, 1 Mar 1998 Abstract
  • Banker D E, Groudine M, Willman C L, Norwood T, Appelbaum F R, Cell cycle perturbations in acute myeloid leukemia samples following in vitro exposures to therapeutic agents., Leukemia Research, 22(3), 221-39, March 1998 Abstract
  • Banker, D.E, Groudine, M, Willman, C.L, Norwood, T, Appelbaum, F.R., Cell cycle perturbations in acute myeloid leukemia samples following in vitro exposures to therapeutic agents, Leukemia Research, 22, 221-239, 1998
  • Banker, D.E, Radich, J, Becker, A, Kerkof, K, Norwood, T, Willman, C, Appelbaum, F.R., The t(8;21) translocation is not consistently associated with high Bcl-2 expression in de novo acute myeloid leukemias of adults, Clinical Cancer Research, 4, 3051-3062, 1998
  • Sullivan KM, Kansu E, Storer B, Jocom J, Emerson G, Reagan T, Emerson V, Siadak MF, Davis C, Appelbaum FR, Buckner CD, Hansen JA, Shulman HM, Storb R, McDonald GB, Intravenous immunoglobulin and the risk of hepatic veno-occlusive disease after bone marrow transplantation, Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation., 4(1), 20-6, 1998 Abstract
  • Storek J, Gooley T, Siadak M, Bensinger W I, Maloney D G, Chauncey T R, Flowers M, Sullivan K M, Witherspoon R P, Rowley S D, Hansen J A, Storb R, Appelbaum F R, Allogeneic peripheral blood stem cell transplantation may be associated with a high risk of chronic graft-versus-host disease., Blood, 90(12), 4705-9, 15 Dec 1997 Abstract
  • Appelbaum F R, Kopecky K J, Long-term survival after chemotherapy for acute myeloid leukemia: the experience of the Southwest Oncology Group., Cancer, 80(11 Suppl), 2199-204, 1 Dec 1997 Abstract
  • Chen C S, Seidel K, Armitage J O, Fay J W, Appelbaum F R, Horowitz M M, Shpall E J, Weiden P L, Antman K S, Champlin R E, Kersey J H, Sullivan K M, Safeguarding the administration of high-dose chemotherapy: a national practice survey by the American Society for Blood and Marrow Transplantation., Biology of Blood and Marrow Transplantation, 3(6), 331-40, December 1997 Abstract
  • Schuening F G, von Kalle C, Kiem H P, Appelbaum F R, Deeg H J, Pepe M, Gooley T, Graham T C, Hackman R C, Storb R, Effect of recombinant canine stem cell factor, a c-kit ligand, on hematopoietic recovery after DLA-identical littermate marrow transplants in dogs., Experimental Hematology, 25(12), 1240-5, November 1997 Abstract
  • Schiffman K, Buckner C D, Maziarz R, Maloney D G, Appelbaum F R, Press O, Gooley T, Holmberg L, Lilleby K, Clift R, Zuckerman N, Klarnet J, Weaver C, Chauncey T, Bensinger W I, High-dose busulfan, melphalan, and thiotepa followed by autologous peripheral blood stem cell transplantation in patients with aggressive lymphoma or relapsed Hodgkin's disease., Biology of Blood and Marrow Transplantation, 3(5), 261-6, November 1997 Abstract
  • Tallman M S, Andersen J W, Schiffer C A, Appelbaum F R, Feusner J H, Ogden A, Shepherd L, Willman C, Bloomfield C D, Rowe J M, Wiernik P H, All-trans-retinoic acid in acute promyelocytic leukemia [see comments], New England Journal of Medicine, 337(15), 1021-8, 9 Oct 1997 Abstract
  • Storb R, Leisenring W, Anasetti C, Appelbaum F R, Deeg H J, Doney K, Martin P, Sullivan K M, Witherspoon R, Pettinger M, Bensinger W, Buckner C D, Clift R, Flowers M E, Hansen J A, Pepe M, Chauncey T, Sanders J, Thomas E D, Methotrexate and cyclosporine for graft-vs.-host disease prevention: what length of therapy with cyclosporine?, Biology of Blood and Marrow Transplantation, 3(4), 194-201, October 1997 Abstract
  • Anderson J E, Sale G, Appelbaum F R, Chauncey T R, Storb R, Allogeneic marrow transplantation for primary myelofibrosis and myelofibrosis secondary to polycythaemia vera or essential thrombocytosis., British Journal of Haematology, 98(4), 1010-6, September 1997 Abstract
  • Gallagher R E, Willman C L, Slack J L, Andersen J W, Li Y P, Viswanatha D, Bloomfield C D, Appelbaum F R, Schiffer C A, Tallman M S, Wiernik P H, Association of PML-RAR alpha fusion mRNA type with pretreatment hematologic characteristics but not treatment outcome in acute promyelocytic leukemia: an intergroup molecular study., Blood, 90(4), 1656-63, 15 Aug 1997 Abstract
  • Sierra J, Radich J, Hansen J A, Martin P J, Petersdorf E W, Bjerke J, Bryant E, Nash R A, Sanders J E, Storb R, Sullivan K M, Appelbaum F R, Anasetti C, Marrow transplants from unrelated donors for treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia., Blood, 90(4), 1410-4, 15 Aug 1997 Abstract
  • Anderson J E, Appelbaum F R, Myelodysplasia and myeloproliferative disorders., Current Opinion In Hematology, 4(4), 261-7, July 1997 Abstract
  • Bensinger W I, Schiffman K S, Holmberg L, Appelbaum F R, Maziarz R, Montgomery P, Ellis E, Rivkin S, Weiden P, Lilleby K, Rowley S, Petersdorf S, Klarnet J P, Nichols W, Hertler A, McCroskey R, Weaver C H, Buckner C D, High-dose busulfan, melphalan, thiotepa and peripheral blood stem cell infusion for the treatment of metastatic breast cancer., Bone Marrow Transplantation, 19(12), 1183-9, June 1997 Abstract
  • Sierra J, Storer B, Hansen J A, Bjerke J W, Martin P J, Petersdorf E W, Appelbaum F R, Bryant E, Chauncey T R, Sale G, Sanders J E, Storb R, Sullivan K M, Anasetti C, Transplantation of marrow cells from unrelated donors for treatment of high-risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose., Blood, 89(11), 4226-35, 1 Jun 1997 Abstract
  • Storb R, Leisenring W, Anasetti C, Appelbaum F R, Buckner C D, Bensinger W I, Chauncey T, Clift R A, Deeg H J, Doney K C, Flowers M E, Hansen J A, Martin P J, Sanders J E, Sullivan K M, Witherspoon R P, Long-term follow-up of allogeneic marrow transplants in patients with aplastic anemia conditioned by cyclophosphamide combined with antithymocyte globulin [letter], Blood, 89(10), 3890-1, 15 May 1997 Abstract
  • Deeg H J, Lin D, Leisenring W, Boeckh M, Anasetti C, Appelbaum F R, Chauncey T R, Doney K, Flowers M, Martin P, Nash R, Schoch G, Sullivan K M, Witherspoon R P, Storb R, Cyclosporine or cyclosporine plus methylprednisolone for prophylaxis of graft-versus-host disease: a prospective, randomized trial., Blood, 89(10), 3880-7, 15 May 1997 Abstract
  • Appelbaum F R, Allogeneic stem cell transplantation for the treatment of hematologic malignancies: current indications and challenges., Journal of rheumatology. Supplement, 48, 41-5, May 1997 Abstract
  • Appelbaum F R, Graft versus leukemia (GVL) in the therapy of acute lymphoblastic leukemia (ALL)., Leukemia, 11 Suppl 4, S15-7, May 1997 Abstract
  • Leith C P, Kopecky K J, Godwin J, McConnell T, Slovak M L, Chen I M, Head D R, Appelbaum F R, Willman C L, Acute myeloid leukemia in the elderly: assessment of multidrug resistance (MDR1) and cytogenetics distinguishes biologic subgroups with remarkably distinct responses to standard chemotherapy. A Southw, Blood, 89(9), 3323-9, 1 May 1997 Abstract
  • Slattery J T, Clift R A, Buckner C D, Radich J, Storer B, Bensinger W I, Soll E, Anasetti C, Bowden R, Bryant E, Chauncey T, Deeg H J, Doney K C, Flowers M, Gooley T, Hansen J A, Martin P J, McDonald G B, Nash R, Petersdorf E W, Sanders J E, Schoch G, Stewart P, Storb R, Appelba, Marrow transplantation for chronic myeloid leukemia: the influence of plasma busulfan levels on the outcome of transplantation., Blood, 89(8), 3055-60, 15 Apr 1997 Abstract
  • Radich J, Gehly G, Lee A, Avery R, Bryant E, Edmands S, Gooley T, Kessler P, Kirk J, Ladne P, Thomas E D, Appelbaum F R, Detection of bcr-abl transcripts in Philadelphia chromosome-positive acute lymphoblastic leukemia after marrow transplantation., Blood, 89(7), 2602-9, 1 Apr 1997 Abstract
  • Anderson J E, Gooley T A, Schoch G, Anasetti C, Bensinger W I, Clift R A, Hansen J A, Sanders J E, Storb R, Appelbaum F R, Stem cell transplantation for secondary acute myeloid leukemia: evaluation of transplantation as initial therapy or following induction chemotherapy., Blood, 89(7), 2578-85, 1 Apr 1997 Abstract
  • Robinson N, Benyunes M C, Thompson J A, York A, Petersdorf S, Press O, Lindgren C, Chauncey T, Buckner C D, Bensinger W I, Appelbaum F R, Fefer A, Interleukin-2 after autologous stem cell transplantation for hematologic malignancy: a phase I/II study., Bone Marrow Transplantation, 19(5), 435-42, March 1997 Abstract
  • Demirer T, Buckner C D, Storer B, Lilleby K, Rowley S, Clift R, Appelbaum F R, Storb R, Bensinger W I, Effect of different chemotherapy regimens on peripheral-blood stem-cell collections in patients with breast cancer receiving granulocyte colony-stimulating factor., Journal of Clinical Oncology, 15(2), 684-90, February 1997 Abstract
  • Appelbaum F R, Allogeneic hematopoietic stem cell transplantation for acute leukemia., Seminars In Oncology, 24(1), 114-23, February 1997 Abstract
  • Doney K, Leisenring W, Storb R, Appelbaum F R, Primary treatment of acquired aplastic anemia: outcomes with bone marrow transplantation and immunosuppressive therapy. Seattle Bone Marrow Transplant Team [see comments], Annals of Internal Medicine, 126(2), 107-15, 15 Jan 1997 Abstract
  • Matthews D C, Appelbaum F R, Press O W, Eary J F, Bernstein I D, The use of radiolabeled antibodies in bone marrow transplantation for hematologic malignancies., Cancer Treatment and Research, 77, 121-39, 1997 Abstract
  • Banker D E, Groudine M, Norwood T, Appelbaum F R, Measurement of spontaneous and therapeutic agent-induced apoptosis with BCL-2 protein expression in acute myeloid leukemia., Blood, 89(1), 243-55, 1 Jan 1997 Abstract
  • Banker, D.E, Groudine, M, Norwood, T, Appelbaum, F.R., Measurement of spontaneous and therapeutic agent-induced apoptosis with BCL-2 protein expression in acute myeloid leukemia, Blood, 89, 243-255, 1997
  • Tsai T, Davalath S, Rankin C, Radich J P, Head D, Appelbaum F R, Boldt D H, Tumor suppressor gene alteration in adult acute lymphoblastic leukemia (ALL). Analysis of retinoblastoma (Rb) and p53 gene expression in lymphoblasts of patients with de novo, relapsed, or refractory, Leukemia, 10(12), 1901-10, December 1996 Abstract
  • Bensinger W I, Buckner C D, Shannon-Dorcy K, Rowley S, Appelbaum F R, Benyunes M, Clift R, Martin P, Demirer T, Storb R, Lee M, Schiller G, Transplantation of allogeneic CD34+ peripheral blood stem cells in patients with advanced hematologic malignancy., Blood, 88(11), 4132-8, 1 Dec 1996 Abstract
  • Corcoran M C, Press O W, Matthews D C, Appelbaum F R, Bernstein I D, The role of radioimmunotherapy in bone marrow transplantation., Current Opinion In Hematology, 3(6), 438-45, November 1996 Abstract
  • Weick J K, Kopecky K J, Appelbaum F R, Head D R, Kingsbury L L, Balcerzak S P, Bickers J N, Hynes H E, Welborn J L, Simon S R, Grever M, A randomized investigation of high-dose versus standard-dose cytosine arabinoside with daunorubicin in patients with previously untreated acute myeloid leukemia: a Southwest Oncology Group study., Blood, 88(8), 2841-51, 15 Oct 1996 Abstract
  • Huss R, Deeg H J, Gooley T, Bryant E, Leisenring W, Clift R, Buckner C D, Martin P, Storb R, Appelbaum F R, Effect of mixed chimerism on graft-versus-host disease, disease recurrence and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemia., Bone Marrow Transplantation, 18(4), 767-76, October 1996 Abstract
  • Bensinger W I, Clift R, Martin P, Appelbaum F R, Demirer T, Gooley T, Lilleby K, Rowley S, Sanders J, Storb R, Buckner C D, Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantation., Blood, 88(7), 2794-800, 1 Oct 1996 Abstract
  • Bensinger W I, Buckner C D, Anasetti C, Clift R, Storb R, Barnett T, Chauncey T, Shulman H, Appelbaum F R, Allogeneic marrow transplantation for multiple myeloma: an analysis of risk factors on outcome., Blood, 88(7), 2787-93, 1 Oct 1996 Abstract
  • McSweeney P A, Rouleau K A, Storb R, Bolles L, Wallace P M, Beauchamp M, Krizanac-Bengez L, Moore P, Sale G, Sandmaier B, de Revel T, Appelbaum F R, Nash R A, Canine CD34: cloning of the cDNA and evaluation of an antiserum to recombinant protein., Blood, 88(6), 1992-2003, 15 Sep 1996 Abstract
  • Bensinger W I, Demirer T, Buckner C D, Appelbaum F R, Storb R, Lilleby K, Weiden P, Bluming A Z, Fefer A, Syngeneic marrow transplantation in patients with multiple myeloma., Bone Marrow Transplantation, 18(3), 527-31, September 1996 Abstract
  • Kiem H P, Leisenring W, Raff R, Deeg H J, Schuening F G, Appelbaum F R, Storb R, Failure of recombinant stem cell factor to enhance engraftment of L-leucyl-L-leucine methyl ester treated canine marrow after irradiation [letter], Blood, 88(5), 1896-7, 1 Sep 1996 Abstract
  • Martin P J, Nelson B J, Appelbaum F R, Anasetti C, Deeg H J, Hansen J A, McDonald G B, Nash R A, Sullivan K M, Witherspoon R P, Scannon P J, Friedmann N, Storb R, Evaluation of a CD5-specific immunotoxin for treatment of acute graft-versus-host disease after allogeneic marrow transplantation., Blood, 88(3), 824-30, 1 Aug 1996 Abstract
  • Brunvand M W, Bensinger W I, Soll E, Weaver C H, Rowley S D, Appelbaum F R, Lilleby K, Clift R A, Gooley T A, Press O W, Fefer A, Storb R, Sanders J E, Martin P L, Chauncey T, Maziarz R T, Zuckerman N, Montgomery P, Dorn R, Weiden P L, Demirer T, Holmberg L A, Schiffman K, McSw, High-dose fractionated total-body irradiation, etoposide and cyclophosphamide for treatment of malignant lymphoma: comparison of autologous bone marrow and peripheral blood stem cells., Bone Marrow Transplantation, 18(1), 131-41, July 1996 Abstract
  • Demirer T, Petersen F B, Bensinger W I, Appelbaum F R, Fefer A, Rowley S, Sanders J, Chauncey T, Storb R, Lilleby K, Buckner C D, Autologous transplantation with peripheral blood stem cells collected after granulocyte colony-stimulating factor in patients with acute myelogenous leukemia., Bone Marrow Transplantation, 18(1), 29-34, July 1996 Abstract
  • Schiffman K S, Bensinger W I, Appelbaum F R, Rowley S, Lilleby K, Clift R A, Weaver C H, Demirer T, Sanders J E, Petersdorf S, Gooley T, Weiden P, Zuckerman N, Montgomery P, Maziarz R, Klarnet J P, Rivkin S, Trueblood K, Storb R, Holmberg L, Buckner C D, Phase II study of high-dose busulfan, melphalan and thiotepa with autologous peripheral blood stem cell support in patients with malignant disease., Bone Marrow Transplantation, 17(6), 943-50, June 1996 Abstract
  • Demirer T, Buckner C D, Gooley T, Appelbaum F R, Rowley S, Chauncey T, Lilleby K, Storb R, Bensinger W I, Factors influencing collection of peripheral blood stem cells in patients with multiple myeloma., Bone Marrow Transplantation, 17(6), 937-41, June 1996 Abstract
  • Kiem H P, McDonald G B, Myerson D, Spurgeon C L, Deeg H J, Sanders J E, Doney K, Appelbaum F R, Sullivan K M, Witherspoon R P, Storb R, Marrow transplantation for hepatitis-associated aplastic anemia: a follow-up of long-term survivors., Biology of Blood and Marrow Transplantation, 2(2), 93-9, May 1996 Abstract
  • Walters M C, Patience M, Leisenring W, Eckman J R, Buchanan G R, Rogers Z R, Olivieri N E, Vichinsky E, Davies S C, Mentzer W C, Powars D, Scott J P, Bernaudin F, Ohene-Frempong K, Darbyshire P J, Wayne A, Roberts I A, Dinndorf P, Brandalise S, Sanders J E, Matthews D C, Appe, Barriers to bone marrow transplantation for sickle cell anemia., Biology of Blood and Marrow Transplantation, 2(2), 100-4, May 1996 Abstract
  • Demirer T, Buckner C D, Appelbaum F R, Clift R, Storb R, Myerson D, Lilleby K, Rowley S, Bensinger W I, High-dose busulfan and cyclophosphamide followed by autologous transplantation in patients with advanced breast cancer., Bone Marrow Transplantation, 17(5), 769-74, May 1996 Abstract
  • Appelbaum F R, The use of bone marrow and peripheral blood stem cell transplantation in the treatment of cancer [see comments], Ca: A Cancer Journal for Clinicians, 46(3), 142-64, May 1996 Abstract
  • Doney K, Storb R, Lilleby K, Appelbaum F R, Recombinant interleukin-1 followed by immunosuppressive therapy for aplastic anemia [letter], American Journal of Hematology, 52(1), 61-2, May 1996